Nanoparticle‐Mediated Blocking of Excessive Inflammation for Prevention of Heart Failure Following Myocardial Infarction

Author:

Kwon Sung Pil1,Hwang Byung‐Hee2,Park Eun‐Hye2,Kim Han Young1,Lee Ju‐Ro1,Kang Mikyung3,Song Seuk Young1,Jung Mungyo1,Sohn Hee Su2,Kim Eunmin2,Kim Chan Woo2,Lee Kwan Yong2,Oh Gyu Chul2,Choo Eunho2,Lim Songhyun1,Chung Yeonseok4,Chang Kiyuk25,Kim Byung‐Soo136ORCID

Affiliation:

1. School of Chemical and Biological Engineering Seoul National University Seoul 08826 Republic of Korea

2. Cardiovascular Research Institute for Intractable Disease Division of Cardiology Seoul St. Mary's Hospital College of Medicine The Catholic University of Korea Seoul 06591 Republic of Korea

3. Interdisciplinary Program for Bioengineering Seoul National University Seoul 08826 Republic of Korea

4. Laboratory of Immune Regulation Research Institute of Pharmaceutical Sciences Seoul National University Seoul 08826 Republic of Korea

5. Division of Cardiology Department of Internal Medicine Seoul St. Mary's Hospital College of Medicine The Catholic University of Korea Seoul 06591 Republic of Korea

6. Institute of Chemical Processes Institute of Engineering Research BioMAX Seoul National University Seoul 08826 Republic of Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3